Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.

Journal: Cerebellum (London, England)

Volume: 15

Issue: 5

Year of Publication: 2017

Affiliated Institutions:  The Weinberg Child Development Center, Edmond and Lily Safra Children's Hospital, Tel Hashomer, Israel. Lidia.Gabis@sheba.health.gov.il. Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Tel Hashomer, Israel. The Danek Gertner Institute of Human Genetics, Tel Hashomer, Israel. The Weinberg Child Development Center, Edmond and Lily Safra Children's Hospital, Tel Hashomer, Israel. IVF Unit, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Abstract summary 

Fragile X syndrome (FXS) is the most prevalent known genetically inherited cause for autism and intellectual disability. Premutation state can cause several clinical disorders as well. We aimed to perform a nesting approach to acquire data with regard to first degree relatives of index fragile X cases at the largest child development center in Israel in order to map characteristics of Israeli FXS permutation women carriers. Seventy-nine women were referred due to a related fragile X syndrome patient, mainly an offspring or sibling. General information regarding demographics, ethnicity, and associated medical conditions were collected using interviews and structured questionnaires. Thirteen (17 %) of the women who were referred as "carrier" were proven to be actually full mutation. The mean years of education were 14 (±1.51, range 12-17). Twenty-one women (27 %) originated from Tunisia (mainly from the island of Djerba). Ten women (13 %) reported delivery of their affected offspring beyond 41 gestational weeks. Twenty-two percent of women with premutation reported symptoms consistent with learning difficulties, mainly dyscalculia, and 14 % reported ADHD symptoms. Awareness about clinical disorders of the carriers was existent only in 25 % of the patients. Increased awareness and knowledge dissemination concerning premutation symptomatology and associated medical conditions are warranted. We suggest a national registry to be installed in different countries in order to identify fragile X premutation carriers at increased risk for various medical complications.

Authors & Co-authors:  Gabis Lidia V LV Gruber Noah N Berkenstadt Michal M Shefer Shahar S Attia Odelia Leon OL Mula Dana D Cohen Yoram Y Elizur Shai E SE

Study Outcome 

Source Link: Visit source

Statistics
Citations :  J Dev Behav Pediatr. 2006 Apr;27(2 Suppl):S137-44
Authors :  8
Identifiers
Doi : 10.1007/s12311-016-0804-y
SSN : 1473-4230
Study Population
Women
Mesh Terms
Educational Status
Other Terms
Carrier;FMR1;FMRP;Fragile X;Premutation
Study Design
Cross Sectional Study
Study Approach
Country of Study
Tunisia
Publication Country
United States